Roivant Sciences
vcUSAseed series-a series-b
Roivant Sciences is a biopharmaceutical company that discovers, develops, and commercializes new medicines by building agile, focused subsidiary companies called 'Vants'. It has achieved multiple FDA approvals and positive Phase 3 trials since 2019. While it creates and invests in its subsidiaries, it is not a traditional venture capital firm; its model aligns incentives for fast execution and rigorous capital allocation in drug development.
Biotechnology Health Care Biopharma